title: Adverse effects of cilostazol on left ventricular function in a patient with a sigmoid shaped interventricular septum.
authors.forename: Tomoko
authors.initials: T
authors.lastname: Umazume
authors.forename: Nobusada
authors.initials: N
authors.lastname: Funabashi
authors.forename: Toshihisa
authors.initials: T
authors.lastname: Inoue
authors.forename: Takeshi
authors.initials: T
authors.lastname: Nishi
authors.forename: Taro
authors.initials: T
authors.lastname: Shimizu
authors.forename: Kigen
authors.initials: K
authors.lastname: Jo
authors.forename: Takayasu
authors.initials: T
authors.lastname: Ishikawa
authors.forename: Yasutake
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Akira
authors.initials: A
authors.lastname: Miyazaki
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Kobayashi
mesh_terms: D000077407:Cilostazol; D005260:Female; D006345:Heart Septal Defects, Ventricular / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D058987:Phosphodiesterase 3 Inhibitors / Q000009:adverse effects*; D013777:Tetrazoles / Q000009:adverse effects*; D014463:Ultrasonography; D016277:Ventricular Function, Left / Q000187:drug effects* / Q000502:physiology; D054088:Ventricular Septum / Q000000981:diagnostic imaging / Q000187:drug effects
chemical_list: D058987:Phosphodiesterase 3 Inhibitors; D013777:Tetrazoles; D000077407:Cilostazol